These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 17300648)

  • 1. Cushing syndrome from percutaneous absorption of 1% hydrocortisone ointment in Netherton syndrome.
    Halverstam CP; Vachharajani A; Mallory SB
    Pediatr Dermatol; 2007; 24(1):42-5. PubMed ID: 17300648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's syndrome caused by topical steroid therapy for psoriasis.
    Abma EM; Blanken R; De Heide LJ
    Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous absorption of hydrocortisone increases with long-term administration. In vivo studies in the rhesus monkey.
    Wester RC; Noonan PK; Maibach HI
    Arch Dermatol; 1980 Feb; 116(2):186-8. PubMed ID: 6766708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Topical administration of corticosteroids and their adverse effects].
    Gschwandtner WR
    Wien Klin Wochenschr; 1973 Jan; 85(4):49-54. PubMed ID: 4684064
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of the degree of dispersion and of the type of ointment base on the skin absorption of hydrocortisone and prednisolone ointments].
    Skripkin IuK; Dobrotvorskiĭ AE; Demidova NM; Aliushin MT
    Vestn Dermatol Venerol; 1974 May; 48(5):19-21. PubMed ID: 4839253
    [No Abstract]   [Full Text] [Related]  

  • 6. Cushing's syndrome and adrenal suppression from percutaneous absorption of clobetasol propionate in infants.
    Cherian MP; AbdulJabbar M
    Saudi Med J; 2001 Dec; 22(12):1139-41. PubMed ID: 11802195
    [No Abstract]   [Full Text] [Related]  

  • 7. An infantile Cushing syndrome due to misuse of topical steroid.
    Siklar Z; Bostanci I; Atli O; Dallar Y
    Pediatr Dermatol; 2004; 21(5):561-3. PubMed ID: 15461763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of Netherton's syndrome with topical calcipotriol.
    Godic A; Dragos V
    Eur J Dermatol; 2004; 14(2):115-7. PubMed ID: 15197002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Adrenal insufficiency and iatrogenic Cushing's syndrome by cutaneous absorption of corticosteroids in an 8 month old infant].
    Dandine M; Lavaud J; Besson-Léaud M; Limal JM
    Ann Dermatol Venereol; 1980 Mar; 107(3):191-5. PubMed ID: 7258980
    [No Abstract]   [Full Text] [Related]  

  • 10. Netherton syndrome and trichorrhexis invaginata--a novel diagnostic approach.
    Burk C; Hu S; Lee C; Connelly EA
    Pediatr Dermatol; 2008; 25(2):287-8. PubMed ID: 18429812
    [No Abstract]   [Full Text] [Related]  

  • 11. An infant with Netherton syndrome and persistent pulmonary hypertension requiring extracorporeal membrane oxygenation.
    Macknet CA; Morkos A; Job L; Garberoglio MC; Clark RD; Macknet KD; Peverini RL
    Pediatr Dermatol; 2008; 25(3):368-72. PubMed ID: 18577046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new SPINK5 donor splice site mutation in siblings with Netherton syndrome.
    Tüysüz B; Ojalvo D; Mat C; Zambruno G; Covaciu C; Castiglia D; D'Alessio M
    Acta Derm Venereol; 2010; 90(1):95-6. PubMed ID: 20107740
    [No Abstract]   [Full Text] [Related]  

  • 13. Cushing's syndrome induced by misuse of moderate- to high-potency topical corticosteroids.
    Coureau B; Bussières JF; Tremblay S
    Ann Pharmacother; 2008 Dec; 42(12):1903-7. PubMed ID: 19017822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrocortisone (cortisol) concentration and penetration gradient.
    Kranz G; Schaefer H; Zesch A
    Acta Derm Venereol; 1977; 57(3):269-73. PubMed ID: 71836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of ultrasonics, hydrocortisone ointment and phonophoresis of hydrocortisone ointment on indices of sensory chronaximetry of patients with kraurosis vulae, lichen scleroatrophicus vulvae and pruritus vulvae essentialis].
    Burgudzhieva T
    Vopr Kurortol Fizioter Lech Fiz Kult; 1974; 0(3):267-9. PubMed ID: 4536573
    [No Abstract]   [Full Text] [Related]  

  • 16. Cushing's syndrome secondary to topical corticosteroids abuse.
    Ermis B; Ors R; Tastekin A; Ozkan B
    Clin Endocrinol (Oxf); 2003 Jun; 58(6):795-6. PubMed ID: 12780758
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of topical calcitriol 3 microg/g ointment, a new topical therapy for chronic plaque psoriasis.
    Kircik L
    J Drugs Dermatol; 2009 Aug; 8(8 Suppl):s9-16. PubMed ID: 19702031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing syndrome secondary to topical glucocorticoids.
    Joe EK
    Dermatol Online J; 2003 Oct; 9(4):16. PubMed ID: 14594589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. rAAV2-mediated restoration of LEKTI in LEKTI-deficient cells from Netherton patients.
    Roedl D; Oji V; Buters JT; Behrendt H; Braun-Falco M
    J Dermatol Sci; 2011 Mar; 61(3):194-8. PubMed ID: 21251800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.
    Panahi Y; Moharamzad Y; Beiraghdar F; Naghizadeh MM
    Basic Clin Pharmacol Toxicol; 2009 Feb; 104(2):171-5. PubMed ID: 19143752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.